Get the Stockscreener App
5.75
1.23%
0.07
Reshape Lifesciences Inc Stock (RSLS) Forecast
The Reshape Lifesciences Inc (RSLS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $69.87, representing a +1,115% increase from the current price of $5.75. The highest analyst price target is $70.41, and the lowest is $69.34.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RSLS Price Target
Average 69.87
(+1,115% Upside)
Is Reshape Lifesciences Inc (RSLS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.69 | Neutral |
| STOCH(9,6) | 65.72 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.095 | Buy |
| ADX(14) | 21.32 | Neutral |
| William %R | -22.32 | Neutral |
| CCI(14) | 86.89 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
5.416
Buy
|
5.5527
Buy
|
| MA20 |
5.5635
Buy
|
5.5715
Buy
|
| MA50 |
5.6429
Buy
|
6.1989
Sell
|
| MA100 |
8.1022
Sell
|
7.6626
Sell
|
| MA200 |
9.3664
Sell
|
12.22
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, RSLS could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on RSLS, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 51.69 indicates that RSLS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 65.72 indicates that RSLS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that RSLS is oversold. This suggests that RSLS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.32 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 86.89 indicates that RSLS is still overbought but not to an extreme extent.
Long-term RSLS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Reshape Lifesciences Inc financial reports and earnings history, Reshape Lifesciences Inc (RSLS) stock could reach $63.83 by 2030, $782.50 by 2040 and $1,126.90 by 2050. See the projected annual prices until 2050 of the Reshape Lifesciences Inc stock below:
- Reshape Lifesciences Inc (RSLS) is expected to reach an average price of $357.16 in 2035, with a high prediction of $367.09 and a low estimate of $357.62. This indicates an $6,112% rise from the last recorded price of $5.75.
- Reshape Lifesciences Inc (RSLS) stock is projected to chart a bullish course in 2040, with an average price target of $794.00, representing an $13,709% surge from its current level. The forecast ranges from a conservative $5.5114 to a sky-high $782.50.
- Our analysts predict Reshape Lifesciences Inc (RSLS) to jump 7,758% by 2045, soaring from $452.24 to an average price of $451.83, potentially reaching $470.70. While $452.24 is the low estimate, the potential upside is significant.
- Reshape Lifesciences Inc (RSLS) stock is expected to climb by 2050, reaching an average of $1,107.78, a $19,166% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,126.90 and $1,111.78, respectively, highlighting the market's uncertainty.
Reshape Lifesciences Inc Stock (RSLS) Year by Year Forecast
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2024
Our forecast for RSLS stock price in 2024 now indicates an average price target of $35.27 with a high forecast of $70.41 and a low forecast of $0.1414. The average prediction reflects an increase of +513.46% from the last recorded price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $72.41 | $69.34 | $70.41 | +1,159% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2025
Reshape Lifesciences Inc Stock (RSLS) is expected to reach an average price of $69.87 in 2025, with a high prediction of $77.57 and a low estimate of $62.17. This indicates an +1,115% rise from the last recorded price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $63.07 | $63.57 | $72.97 | +996.85% |
| February, 2025 | $70.30 | $62.17 | $61.60 | +1,123% |
| March, 2025 | $73.53 | $76.33 | $75.66 | +1,179% |
| April, 2025 | $76.55 | $70.07 | $71.61 | +1,231% |
| May, 2025 | $76.62 | $77.52 | $77.57 | +1,233% |
| June, 2025 | $76.63 | $76.19 | $74.15 | +1,233% |
| July, 2025 | $77.86 | $78.38 | $76.41 | +1,254% |
| August, 2025 | $78.03 | $76.73 | $75.54 | +1,257% |
| September, 2025 | $73.85 | $74.87 | $74.14 | +1,184% |
| October, 2025 | $76.79 | $73.63 | $72.80 | +1,235% |
| November, 2025 | $73.97 | $73.97 | $73.92 | +1,186% |
| December, 2025 | $67.95 | $68.52 | $72.22 | +1,082% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2026
The predicted value for Reshape Lifesciences Inc (RSLS) in 2026 is set at an average of $45.67. Estimates vary from a peak of $66.25 to a trough of $25.09, indicating an +694.30% surge from the present price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $66.74 | $66.67 | $66.25 | +1,061% |
| February, 2026 | $63.42 | $63.84 | $65.29 | +1,003% |
| March, 2026 | $61.45 | $61.52 | $62.63 | +968.70% |
| April, 2026 | $56.80 | $56.88 | $60.07 | +887.88% |
| May, 2026 | $52.89 | $52.91 | $55.42 | +819.88% |
| June, 2026 | $49.76 | $49.79 | $51.80 | +765.45% |
| July, 2026 | $45.18 | $45.28 | $48.67 | +685.66% |
| August, 2026 | $41.53 | $41.68 | $44.18 | +622.27% |
| September, 2026 | $37.15 | $37.19 | $40.55 | +546.15% |
| October, 2026 | $33.73 | $33.78 | $36.15 | +486.53% |
| November, 2026 | $29.91 | $29.93 | $32.73 | +420.11% |
| December, 2026 | $25.09 | $25.09 | $28.92 | +336.32% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Reshape Lifesciences Inc (RSLS) is $94.67, with a high forecast of $188.36 and a low forecast of $0.9742. This indicates an +1,546% increase from the last price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.20 | $21.21 | $24.06 | +268.72% |
| February, 2027 | $17.38 | $17.38 | $20.21 | +202.18% |
| March, 2027 | $12.59 | $12.59 | $16.40 | +118.96% |
| April, 2027 | $8.7116 | $8.7128 | $11.60 | +51.51% |
| May, 2027 | $4.8395 | $4.8441 | $7.7155 | -15.83% |
| June, 2027 | $158.67 | $0.9742 | $147.17 | +2,659% |
| July, 2027 | $147.93 | $149.36 | $134.30 | +2,473% |
| August, 2027 | $158.19 | $160.49 | $152.37 | +2,651% |
| September, 2027 | $156.51 | $157.95 | $150.75 | +2,622% |
| October, 2027 | $183.77 | $157.08 | $180.77 | +3,096% |
| November, 2027 | $177.53 | $184.03 | $181.40 | +2,988% |
| December, 2027 | $199.86 | $180.10 | $188.36 | +3,376% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2028
In 2028, Reshape Lifesciences Inc (RSLS) is projected to reach an average price of $179.65, with a high projection of $199.49 and a low estimate of $159.81. This indicates an +3,024% rise from the last price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $199.12 | $203.12 | $199.49 | +3,363% |
| February, 2028 | $199.88 | $198.18 | $197.38 | +3,376% |
| March, 2028 | $185.20 | $185.64 | $197.94 | +3,121% |
| April, 2028 | $191.71 | $181.33 | $186.90 | +3,234% |
| May, 2028 | $174.26 | $185.32 | $190.96 | +2,931% |
| June, 2028 | $186.12 | $181.50 | $183.56 | +3,137% |
| July, 2028 | $181.63 | $182.25 | $184.16 | +3,059% |
| August, 2028 | $178.59 | $178.88 | $176.75 | +3,006% |
| September, 2028 | $172.39 | $173.39 | $175.26 | +2,898% |
| October, 2028 | $169.07 | $170.15 | $168.83 | +2,840% |
| November, 2028 | $160.48 | $160.87 | $165.17 | +2,691% |
| December, 2028 | $158.97 | $159.81 | $158.11 | +2,665% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2029
The 2029 price forecast for Reshape Lifesciences Inc Stock (RSLS) is $111.11 on average, with a high prediction of $156.30 and a low estimate of $65.92. This represents an +1,832% increase from the previous price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $150.32 | $151.56 | $156.30 | +2,514% |
| February, 2029 | $141.46 | $141.96 | $144.08 | +2,360% |
| March, 2029 | $136.59 | $137.76 | $139.25 | +2,275% |
| April, 2029 | $130.50 | $130.65 | $134.26 | +2,169% |
| May, 2029 | $121.47 | $121.60 | $128.58 | +2,013% |
| June, 2029 | $114.05 | $114.11 | $118.14 | +1,883% |
| July, 2029 | $106.17 | $106.32 | $111.83 | +1,746% |
| August, 2029 | $97.58 | $97.66 | $104.17 | +1,597% |
| September, 2029 | $89.86 | $89.88 | $95.42 | +1,463% |
| October, 2029 | $80.67 | $80.68 | $87.83 | +1,303% |
| November, 2029 | $73.27 | $73.29 | $78.71 | +1,174% |
| December, 2029 | $65.91 | $65.92 | $71.28 | +1,046% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2030
Reshape Lifesciences Inc Stock (RSLS) is expected to reach an average price of $162.63 in 2030, with a high forecast of $323.16 and a low forecast of $2.1085. This signifies an +2,728% surge from the last price of $5.75.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $56.21 | $56.23 | $63.83 | +877.52% |
| February, 2030 | $48.46 | $48.49 | $54.26 | +742.75% |
| March, 2030 | $40.74 | $40.75 | $46.18 | +608.54% |
| April, 2030 | $33.02 | $33.02 | $38.73 | +474.24% |
| May, 2030 | $23.38 | $23.41 | $31.08 | +306.69% |
| June, 2030 | $15.63 | $15.65 | $21.44 | +171.80% |
| July, 2030 | $5.9687 | $5.9734 | $13.68 | +3.80% |
| August, 2030 | $317.10 | $2.1085 | $306.00 | +5,415% |
| September, 2030 | $313.49 | $304.89 | $297.49 | +5,352% |
| October, 2030 | $290.97 | $316.18 | $304.43 | +4,960% |
| November, 2030 | $299.86 | $302.36 | $293.86 | +5,115% |
| December, 2030 | $329.76 | $315.96 | $323.16 | +5,635% |
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):